PACB Stock Price, Chart, Stats & News

Pacific Biosciences of California, Inc.
Save
512.49M
Market cap
–
Current P/E
–
Forward P/E
PACB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 28.21% |
Operating margin | -346.11% |
Pretax margin | -341.28% |
Net margin | -341.47% |
Effective tax rate | -0.06% |
ROA | -69.68% |
ROE | -1123.27% |
D/E | 141.98x |
Interest coverage ratio | -79.64x |
PACB valuation
P/E | – |
P/S | 2.38x |
P/B | 71.12x |
P/CF | -3.42x |
P/FCF | -3.07x |
P/OCF | -3.42x |
PEG | 0.08x |
EV multiple | 1.97x |
About
Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are essential consumable products, such as their unique single molecule real-time (SMRT) cells.
Similar securities
Based on sector and market capitalization
Report issue











